{"id":734,"date":"2020-08-24T16:45:02","date_gmt":"2020-08-24T16:45:02","guid":{"rendered":"https:\/\/lorandparajdi.wordpress.com\/?page_id=734"},"modified":"2023-07-17T15:52:13","modified_gmt":"2023-07-17T15:52:13","slug":"theoretical-basis-of-optimal-therapy-for-individual-patients-in-chronic-myeloid-leukemia-a-mathematical-approach","status":"publish","type":"page","link":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/theoretical-basis-of-optimal-therapy-for-individual-patients-in-chronic-myeloid-leukemia-a-mathematical-approach\/","title":{"rendered":"Article no.5"},"content":{"rendered":"\n<p class=\"has-text-align-center\" style=\"font-size:28px\">Theoretical Basis of Optimal Therapy for Individual Patients in Chronic Myeloid Leukemia: A Mathematical Approach<a style=\"display:block; font-size:13px; line-height:3.5em;\"><span style=\"color:#424547\" class=\"has-inline-color\">Research Paper, July 6, 2020 \/ Lorand Gabriel Parajdi<\/span><\/a><\/p>\n\n\n\n<p style=\"font-size:15px\">Published in Taylor &amp; Francis Online,<em><em>&nbsp;Journal of Interdisciplinary Mathematics<\/em>&nbsp;23(3),&nbsp;669-690,<\/em> <a style=\"display:block; color:#474747;\"><\/a>DOI: <a rel=\"noreferrer noopener\" href=\"https:\/\/doi.org\/10.1080\/09720502.2019.1681699\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">10.1080\/09720502.2019.1681699<\/span><\/a>, <em>&nbsp;2020<\/em>.<\/p>\n\n\n\n<p style=\"font-size:15px\"><img decoding=\"async\" loading=\"lazy\" width=\"267\" height=\"328\" class=\"wp-image-2308\" style=\"width: 18px;\" src=\"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-content\/uploads\/2020\/10\/pdf_logo.png\" alt=\"\" srcset=\"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-content\/uploads\/2020\/10\/pdf_logo.png 267w, https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-content\/uploads\/2020\/10\/pdf_logo-244x300.png 244w\" sizes=\"(max-width: 267px) 100vw, 267px\" \/><strong><span class=\"has-inline-color has-black-color\">&nbsp;&nbsp;Paper is available on the Taylor &amp; Francis Online, Journal of Interdisciplinary Mathematics website:<\/span><\/strong> <a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/09720502.2019.1681699\" target=\"_blank\">https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/09720502.2019.1681699<\/a><a style=\"display:block; color:#474747;\"><\/a><\/p>\n\n\n\n<p style=\"font-size:15px\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-black-color\">Authors:<\/mark><\/strong>  Lorand Gabriel Parajdi<sup>1<\/sup>,  Radu Precup<sup>1<\/sup>,  Delia Dima<sup>3<\/sup>,  Vlad Moisoiu<sup>2,3<\/sup> and Ciprian Tomuleasa<sup>3<\/sup><\/p>\n\n\n\n<p style=\"font-size:15px\"><a style=\"display:block; color:#474747;\"><\/a><sup>1 <\/sup>Department of Mathematics, &#8220;Babe\u015f\u2013Bolyai&#8221; University, Cluj-Napoca, Romania<a style=\"display:block; color:#474747;\"><\/a><sup>2 <\/sup>IMOGEN Research Institute County Clinical Emergency Hospital, Cluj-Napoca, Romania<a style=\"display:block; color:#474747;\"><\/a><sup>3 <\/sup>Department of Hematology, &#8220;Ion Chiricu\u0163\u0103&#8221; Clinical Cancer Center, Cluj-Napoca, Romania<\/p>\n\n\n\n<p style=\"font-size:15px\"><strong><span class=\"has-inline-color has-black-color\">Abstract:<\/span><\/strong>  Even if the successful pharmacological therapy for chronic myeloid leukemia has reached today a near normal life expectancy in a patient diagnosed with this malignancy, almost one in four patients will change the line of tyrosin-kinase inhibitors during therapy, may it be due to poor response of due to intolerance to therapy. In this paper, starting from a mathematical characterization of the chronic phase in myeloid leukemia, a theoretical investigation of optimal therapy is undertaken as base for further pharmaceutical research and personalized treatment protocols.<\/p>\n\n\n\n<p style=\"font-size:15px\"><strong><span class=\"has-inline-color has-black-color\">Subject Classification:<\/span><\/strong>  92B05, 92D25, 92C50<\/p>\n\n\n\n<p style=\"font-size:15px\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-black-color\"><strong>Keywords<\/strong>:<\/mark>  Mathematical model; Chronic myeloid leukemia; Dynamic system; Optimization problem.<\/p>\n\n\n\n<p style=\"font-size:15px\"><strong><span class=\"has-inline-color has-black-color\">Cite As:<\/span><\/strong>  Lorand Gabriel Parajdi, Radu Precup, Delia Dima, Vlad Moisoiu &amp; Ciprian Tomuleasa&nbsp;(2020)&nbsp;Theoretical basis of optimal therapy for individual patients in chronic myeloid leukemia: A mathematical approach,&nbsp;Journal of Interdisciplinary Mathematics,&nbsp;23:3,&nbsp;669-690,&nbsp;    DOI:&nbsp;10.1080\/09720502.2019.1681699.<\/p>\n\n\n\n<p style=\"font-size:15px\"><strong><span class=\"has-inline-color has-black-color\">References:<\/span><\/strong>   <br><strong><span class=\"has-inline-color has-black-color\">1.<\/span><\/strong> Tomuleasa,&nbsp;C.,&nbsp;D. Dima,&nbsp;I. Frinc,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>BCR-ABL1 T315I mutation, a negative prognostic factor for the terminal phase of chronic myelogenous leukemia treated with first- and second-line tyrosine kinase inhibitors, might be an indicator of allogeneic stem cell transplant as the treatment of choice.<\/em>&nbsp;Leuk Lymphoma, (<strong>2014<\/strong>) 56:&nbsp;546-7. &nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0001&amp;dbid=20&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.3109%2F10428194.2014.940582&amp;tollfreelink=2_239_ba5ca3a548f322a911f839406847ada2fe6f0e103e9e40b65f358898b42ddba4\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Taylor &amp; Francis Online]<\/span><\/a>,&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/scholar.google.com\/scholar_lookup?hl=en&amp;publication_year=2014&amp;pages=546-7&amp;author=C.+Tomuleasa&amp;author=D.+Dima&amp;author=I.+Frinc&amp;title=BCR-ABL1+T315I+mutation%2C+a+negative+prognostic+factor+for+the+terminal+phase+of+chronic+myelogenous+leukemia+treated+with+first-+and+second-line+tyrosine+kinase+inhibitors%2C+might+be+an+indicator+of+allogeneic+stem+cell+transplant+as+the+treatment+of+choice\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Google Scholar]<\/span><\/a>          <br><br><span class=\"has-inline-color has-black-color\"><strong>2.<\/strong><\/span> Hochhaus,&nbsp;A.&nbsp;,&nbsp;S. Saussele,&nbsp;G. Rosti,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.<\/em>&nbsp;Annals of Oncology. (<strong>2017<\/strong>) 28(suppl 4):&nbsp;iv41-iv51.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0002&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1093%2Fannonc%2Fmdx219\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>       <br><br><strong><span class=\"has-inline-color has-black-color\">3.<\/span><\/strong> Timis,&nbsp;T.&nbsp;,&nbsp;C. Berce,&nbsp;A. Duarte-Garcia,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>Paraneoplastic syndromes with connective tissue involvement. \u201cIt\u2019s not always lupus!\u201d<\/em>,&nbsp;J. BUON. (<strong>2012<\/strong>) 17:&nbsp;417-21.&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/scholar.google.com\/scholar_lookup?hl=en&amp;publication_year=2012&amp;pages=417-21&amp;author=T.+Timis&amp;author=C.+Berce&amp;author=A.+Duarte-Garcia&amp;title=Paraneoplastic+syndromes+with+connective+tissue+involvement.+%E2%80%9CIt%E2%80%99s+not+always+lupus%21%E2%80%9D\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Google Scholar]<\/span><\/a>   <br><br><strong><span class=\"has-inline-color has-black-color\">4.<\/span><\/strong> Frinc,&nbsp;I.&nbsp;,&nbsp;M.S. Muresan,&nbsp;F. Zaharie,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>Cancer stem-like cells: the dark knights of clinical hematology and oncology.<\/em>&nbsp;J. BUON. (<strong>2014<\/strong>) 19(2):&nbsp;328-35. <a rel=\"noreferrer noopener\" href=\"http:\/\/scholar.google.com\/scholar_lookup?hl=en&amp;publication_year=2014&amp;pages=328-35&amp;issue=2&amp;author=I.+Frinc&amp;author=M.S.+Muresan&amp;author=F.+Zaharie&amp;title=Cancer+stem-like+cells%3A+the+dark+knights+of+clinical+hematology+and+oncology\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Google Scholar]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">5.<\/span><\/strong> Adimy,&nbsp;M.&nbsp;,&nbsp;F. Crauste&nbsp;and&nbsp;S. Ruan&nbsp;.&nbsp;<em>A mathematical study of the hematopoiesis process with applications to chronic myelogenous leukemia.<\/em>&nbsp;SIAM J. Appl. Math. (<strong>2005<\/strong>)&nbsp;65:&nbsp;1328\u20131352.&nbsp;&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0005&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1137%2F040604698\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">6.<\/span><\/strong> Dale,&nbsp;D.C.&nbsp;and&nbsp;M.C. Mackey&nbsp;.&nbsp;<em>Understanding, treating and avoiding hematological disease: Better medicine through mathematics?<\/em>&nbsp;Bull. Math. Biol. (<strong>2015<\/strong>)&nbsp;77:&nbsp;739\u2013757.&nbsp; <a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0006&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2Fs11538-014-9995-x\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">7.<\/span><\/strong> Foley,&nbsp;C.&nbsp;and&nbsp;M.C. Mackey&nbsp;.&nbsp;<em>Dynamic hematological disease: a review.<\/em>&nbsp;J. Math. Biol.&nbsp;(<strong>2009<\/strong>) 58:&nbsp;285\u2013322. &nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0007&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2Fs00285-008-0165-3\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">8.<\/span><\/strong> He,&nbsp;Q.&nbsp;,&nbsp;J. Zhu,&nbsp;D. Dingli,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>Optimized treatment schedules for chronic myeloid leukemia.<\/em>&nbsp;PLoS Comput. Biol. (<strong>2016<\/strong>)&nbsp;12(10):&nbsp;e1005129.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0008&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1371%2Fjournal.pcbi.1005129\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">9.<\/span><\/strong> Jayachandran,&nbsp;D.&nbsp;,&nbsp;A.E. Rundell,&nbsp;R.E. Hannemann,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>Optimal chemotherapy for leukemia: a model-based strategy for individualized treatment.<\/em>&nbsp;PLoS ONE (<strong>2014<\/strong>)&nbsp;9(10):&nbsp;e109623.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0009&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1371%2Fjournal.pone.0109623\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">10.<\/span><\/strong> Kaplan,&nbsp;D.&nbsp;and&nbsp;L. Glass&nbsp;.&nbsp;<em>Understanding Nonlinear Dynamics<\/em>&nbsp;.&nbsp;New York&nbsp;:&nbsp;Springer&nbsp;(<strong>1995<\/strong>).&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0010&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2F978-1-4612-0823-5\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Book]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">11.<\/span><\/strong> Mac Lean,&nbsp;A.L.&nbsp;,&nbsp;C. Lo Celso&nbsp;and&nbsp;M.P.H. Stumpf&nbsp;.&nbsp;<em>Population dynamics of normal and leukaemia stem cells in the haematopoietic stem cell niche show distinct regimes where leukaemia will be controlled.<\/em>&nbsp;J. R. Soc. Interface &nbsp;(<strong>2013<\/strong>)&nbsp;10:&nbsp;20120968.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0011&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1098%2Frsif.2012.0968\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">12.<\/span><\/strong> Sbeity,&nbsp;H.&nbsp;and&nbsp;R. Younes.&nbsp;<em>Review of optimization methods for cancer chemotherapy treatment planning.<\/em>&nbsp;J. Comput. Sci. Syst. Biol. (<strong>2015<\/strong>)&nbsp;8:&nbsp;74\u201395.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0012&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.4172%2Fjcsb.1000173\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">13.<\/span><\/strong> Mackey,&nbsp;M.C.&nbsp;and&nbsp;L. Glass&nbsp;.&nbsp;<em>Oscillation and chaos in physiological control systems.<\/em>&nbsp;Science (<strong>1977<\/strong>)&nbsp;197:&nbsp;287\u2013289.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0013&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1126%2Fscience.267326\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">14.<\/span><\/strong> Dingli,&nbsp;D.&nbsp;and&nbsp;F. Michor&nbsp;.&nbsp;<em>Successful therapy must eradicate cancer stem cells.<\/em>&nbsp;Stem Cells (<strong>2006<\/strong>)&nbsp;24:&nbsp;2603\u20132610. <a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0014&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1634%2Fstemcells.2006-0136\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">15.<\/span><\/strong> Cucuianu,&nbsp;A.&nbsp;and&nbsp;R. Precup&nbsp;.&nbsp;<em>A hypothetical-mathematical model of acute myeloid leukemia pathogenesis.<\/em>&nbsp;Comput. Math. Methods Med. (<strong>2010<\/strong>)&nbsp;11:&nbsp;49\u201365. <a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0015&amp;dbid=20&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1080%2F17486700902973751&amp;tollfreelink=2_239_0b022b9a42db92e442d7500fee2528763134410e9aca2491c06ee6a11f4de0f9\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Taylor &amp; Francis Online]<\/span><\/a>, <a rel=\"noreferrer noopener\" href=\"http:\/\/scholar.google.com\/scholar_lookup?hl=en&amp;publication_year=2010&amp;pages=49-65&amp;author=A.+Cucuianu&amp;author=R.+Precup&amp;title=A+hypothetical-mathematical+model+of+acute+myeloid+leukemia+pathogenesis\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Google Scholar]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">16.<\/span><\/strong> Parajdi,&nbsp;L.&nbsp;<em>Modeling the treatment of tumor cells in a solid tumor.<\/em>&nbsp;J. Nonlinear Sci. Appl. (<strong>2014<\/strong>)&nbsp;7(3):&nbsp;188\u2013195. <a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0016&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.22436%2Fjnsa.007.03.05\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">17.<\/span><\/strong> Michor,&nbsp;F.&nbsp;,&nbsp;T.P. Hughes,&nbsp;Y. Iwasa,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>Dynamics of chronic myeloid leukaemia.<\/em>&nbsp;Nature (<strong>2005<\/strong>)&nbsp;435:&nbsp;1267\u20131270. <a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0017&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1038%2Fnature03669\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">18.<\/span><\/strong> Precup,&nbsp;R.&nbsp;,&nbsp;S. Arghirescu,&nbsp;A. Cucuianu,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>Mathematical modeling of cell dynamics after allogeneic bone marrow transplantation in acute myeloid leukemia.<\/em>&nbsp;Int. J. Biomath. (<strong>2012<\/strong>)&nbsp;5:&nbsp;1250026&nbsp;[18 pages].&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0018&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1142%2FS1793524511001684\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">19.<\/span><\/strong> Precup,&nbsp;R.&nbsp;,&nbsp;M.A. Serban,&nbsp;D. Trif,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>A planning algorithm for correction therapies after allogeneic stem cell transplantation.<\/em>&nbsp;J. Math. Model. Algor. (<strong>2012<\/strong>)&nbsp;11:&nbsp;309\u2013323.  <a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0019&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2Fs10852-012-9187-3\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">20.<\/span><\/strong> Precup,&nbsp;R.&nbsp;<em>Mathematical understanding of the autologous stem cell transplantation.<\/em>&nbsp;Ann. Tiberiu Popoviciu Semin. Funct. Equ. Approx. Convexity (<strong>2012<\/strong>)&nbsp;10:&nbsp;155-167.&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/scholar.google.com\/scholar_lookup?hl=en&amp;publication_year=2012&amp;pages=155-167&amp;author=R.+Precup&amp;title=Mathematical+understanding+of+the+autologous+stem+cell+transplantation\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Google Scholar]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">21.<\/span><\/strong> Parajdi,&nbsp;L.G.&nbsp;,&nbsp;R. Precup,&nbsp;E.A. Bonci&nbsp;and&nbsp;C. Tomuleasa&nbsp;.&nbsp;<em>A mathematical model of the transition from the normal hematopoiesis to the chronic and acceleration-acute stages in myeloid leukemia.<\/em> Mathematics (<strong>2020<\/strong>) 8(3):376. &nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.mdpi.com\/2227-7390\/8\/3\/376\/htm\" target=\"_blank\"><\/a><a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0019&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2Fs10852-012-9187-3\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">22.<\/span><\/strong> Hideo,&nbsp;E.&nbsp;,&nbsp;M. Yohei&nbsp;and&nbsp;S. Toshio&nbsp;.&nbsp;<em>Heterogeneity and hierarchy of hematopoietic stem cells.<\/em>&nbsp;<em>Exp. Hematol.<\/em> (<strong>2014<\/strong>) 42(2):&nbsp;74-82. &nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0022&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1016%2Fj.exphem.2013.11.004\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">23.<\/span><\/strong> Herzenberg,&nbsp;L.A.&nbsp;,&nbsp;D. Parks,&nbsp;B. Sahaf,&nbsp;<em>et al<\/em>&nbsp;.&nbsp;<em>The History and Future of the Fluorescence Activated Cell Sorter and Flow Cytometry: A View from Stanford.<\/em>&nbsp;Clin. Chem. (<strong>2002<\/strong>) 48(10):&nbsp;1819-1827.&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0023&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1093%2Fclinchem%2F48.10.1819\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">24.<\/span><\/strong> Dayneka,&nbsp;N.L.&nbsp;,&nbsp;V. Garg&nbsp;and&nbsp;W.L. Jusko&nbsp;.&nbsp;<em>Comparison of four basic models of indirect pharmacodynamic responses.<\/em>&nbsp;J. Pharmacokinet. Pharmacodyn. (<strong>1993<\/strong>) 21(4):&nbsp;457-478. &nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0024&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2FBF01061691\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Article]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">25.<\/span> <\/strong>Karmanov,&nbsp;V.G.&nbsp;<em>Mathematical Programming<\/em>&nbsp;.&nbsp;Moscow&nbsp;:&nbsp;Mir Publishers&nbsp; (<strong>1989<\/strong>).&nbsp; <a rel=\"noreferrer noopener\" href=\"http:\/\/scholar.google.com\/scholar_lookup?hl=en&amp;publication_year=1989&amp;author=V.G.+Karmanov&amp;title=+Mathematical+Programming+\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Google Scholar]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">26.<\/span><\/strong> Lupt\u00e1\u010cik,&nbsp;M.&nbsp;<em>Mathematical Optimization and Economic Analysis<\/em>&nbsp;.&nbsp;New York&nbsp;:&nbsp;Springer&nbsp;(<strong>2010<\/strong>). &nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0026&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2F978-0-387-89552-9\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Book]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">27.<\/span><\/strong> Heck,&nbsp;A.&nbsp;<em>Introduction to Maple,<\/em>&nbsp;3rd edn.&nbsp;New York&nbsp;:&nbsp;Springer&nbsp;(<strong>2003<\/strong>).&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.tandfonline.com\/servlet\/linkout?suffix=CIT0027&amp;dbid=16&amp;doi=10.1080%2F09720502.2019.1681699&amp;key=10.1007%2F978-1-4613-0023-6\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Book]<\/span><\/a>     <br><br><strong><span class=\"has-inline-color has-black-color\">28.<\/span><\/strong> Parajdi,&nbsp;L.G.&nbsp;<em>Mathematical modeling of cell dynamics and optimization problems in chronic myeloid leukemia therapy<\/em> (Abstract).&nbsp;<em>11th European Conference on Mathematical and Theoretical Biology (ECMTB 2018) &#8211; Book of Abstracts<\/em>&nbsp;. Ed.&nbsp;MairaAguiar&nbsp;.&nbsp;Lisbon:&nbsp;Portuguese Mathematical Society. pp.&nbsp;252-253. <a rel=\"noreferrer noopener\" href=\"http:\/\/www.ecmtb2018.org\/files\/files\/BookOfAbstracts_ECMTB2018_inclusions.pdf\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Book of Abstracts]<\/span><\/a>&nbsp;(<strong>2018<\/strong>).&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/scholar.google.com\/scholar_lookup?hl=en&amp;publication_year=2018&amp;pages=252-253&amp;author=L.G.+Parajdi&amp;title=+11th+European+Conference+on+Mathematical+and+Theoretical+Biology+%28ECMTB+2018%29+-+Book+of+Abstracts+\" target=\"_blank\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">[Google Scholar]<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Theoretical Basis of Optimal Therapy for Individual Patients in Chronic Myeloid Leukemia: A Mathematical ApproachResearch Paper, July 6, 2020 \/ Lorand Gabriel Parajdi Published in Taylor &amp; Francis Online,&nbsp;Journal of Interdisciplinary Mathematics&nbsp;23(3),&nbsp;669-690, DOI: 10.1080\/09720502.2019.1681699, &nbsp;2020. &nbsp;&nbsp;Paper is available on the Taylor &amp; Francis Online, Journal of Interdisciplinary Mathematics website: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/09720502.2019.1681699 Authors: Lorand Gabriel Parajdi1, Radu &hellip; <a href=\"https:\/\/www.cs.ubbcluj.ro\/~lorand\/theoretical-basis-of-optimal-therapy-for-individual-patients-in-chronic-myeloid-leukemia-a-mathematical-approach\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Article no.5<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/pages\/734"}],"collection":[{"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/comments?post=734"}],"version-history":[{"count":31,"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/pages\/734\/revisions"}],"predecessor-version":[{"id":5406,"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/pages\/734\/revisions\/5406"}],"wp:attachment":[{"href":"https:\/\/www.cs.ubbcluj.ro\/~lorand\/wp-json\/wp\/v2\/media?parent=734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}